Coping with breast cancer increasingly becomes a major socio-economic challenge not least due to the constantly rising incidence of the disease in the developing world. There is a growing need for novel strategies to improve understanding and capacity to predict the resilience of women to the variety of stressful experiences and practical challenges related to breast cancer. This is a necessary step toward efficient recovery through personalized interventions. BOUNCE has brought together modelling, medical, and social sciences experts to advance current knowledge on the dynamic nature of resilience as it relates to efficient recovery from breast cancer. BOUNCE considers clinical, cancer-related biological, lifestyle, and psychosocial parameters in order to predict individual resilience trajectories throughout the cancer continuum. Ultimately prediction models and related decision support tools to become available to clinicians aspire to support resilience in breast cancer survivors and help them remain in the workforce and enjoy a better quality of life.
The BOUNCE project is currently in it’s 4th and final year. More importantly, the prospective multi-centre clinical pilot, which is at the core of the project, is underway at four major oncology centres (in Italy, Finland, Israel and Portugal). The clinical study is now tracking the medical and psychosocial trajectories of approximately 550 women who were diagnosed with breast cancer 10-16 months earlier. Participating women are assessed every three months on a long list of potentially relevant variables as they bounce back during the highly stressful treatment and recovery period following the diagnosis of breast cancer.
|Duration:||01/11/2017-31/10/2021 (48 months)|
|Total Budget:||4.999.410 €|
|Project type:||H2020 – SCI-2017-CNECT-2|
|Topic:||SC1-PM-17-2017: Personalized Computer Models and in-silico systems for well-being|
|Funded:||This project has received funding from the European Union’s Horizon 2020 research and innovation programme|
|Grant Agreement Nr.:||777167|
In-Silico Medicine: a new emergent domain embedded in BOUNCE project for supporting breast cancer patients
In silico medicine is an emergent scientific domain based on
Depression and Anxiety in patients with breast cancer: The impact of the Covid-19 pandemic
Patients with cancer frequently experience depressive and anxiety symptoms, which can negatively affect quality of life, adherence to treatment and health service use (1). The reported prevalence of depression and anxiety varies according to cancer-related variables...
“CHEMOBRAIN” How to deal with the cognitive changes during and after treatments?
Breast cancer survivors often experience cognitive changes during and after systemic treatments, mainly chemotherapy [6,7]. Even though this topic has been undervalued for some time, it has been gaining more focus by the scientific and medical communities, driven by...
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 777167
Copyright © 2017-2023, BOUNCE project